Europe Blood Irradiation Market

Historic Data: 2020-2021   |   Base Year: 2022   |   Forecast Period: 2023-2028

Analysis – by Type (Intravenous Laser Blood Irradiation, Transcutaneous Laser Blood Irradiation, and Extracorporeal Blood Irradiation), Indication (Acute Leukemia, Lymphoma, Solid Tumors, Pelvic Tumors, and Others), and End User (Hospitals, Blood Banks, Diagnostics Clinics, and Research Institutes)   


No. of Pages: 109    |    Report Code: BMIRE00027192    |    Category: Life Sciences

Available Report Formats

pdf-format excel-format pptx-format
Request Free Sample Buy Now
Europe Blood Irradiation Market

The blood irradiation market in Europe is expected to grow from US$ 26.90 million in 2022 to US$ 40.24 million by 2028. It is estimated to grow at a CAGR of 6.9% from 2022 to 2028.

 

Rise in Healthcare Expenditure and Government Initiatives Bolsters Europe Blood Irradiation Market

The therapeutic landscape of communicable and noncommunicable diseases is evolving with time and technology, increasing healthcare expenditure, and surging awareness in a large population. X-ray and gamma irradiators are widely used for blood irradiation to ensure patient safety and prevent further complications. Blood irradiation helps manage hematological malignancies and prevents transfusion-associated graft-versus-host (TGVH) disease. The FDA has approved the use of blood irradiators, along with implementing tighter security measures to reduce the risk of unauthorized use of radioactive materials. The Serious Hazards of Blood Transfusion (SHOT) scheme of the UK government supports patient safety by analyzing anonymized information gathered on adverse events and reactions reported by from healthcare organizations involved in the blood and blood components transfusion after the transfusion procedures. Moreover, European Blood Alliance (EBA), Voluntary Blood Donation in Rhodope, and various other government and nongovernment organizations/projects from European countries are creating awareness among people regarding blood donation to fulfill the increasing demand for blood. Thus, such government and nongovernment initiatives for encouraging blood donation are driving the growth of the blood irradiation market.

 

Market Overview

 

Europe is the second-largest market for blood irradiation, and the market growth in this region is attributed to factors such as the rising prevalence of cancer, cardiac stroke, diabetes, and various other noncommunicable chronic diseases. In addition, growing funding for research & development activities is likely to provide opportunities for the market players in the coming years. Moreover, the pharmaceutical industry in Germany holds the fourth largest position with small and mid-sized companies. The country is likely to remain one of the most attractive destinations for the Europe healthcare industry over the coming years in terms of treatment. The industry's growth is driven by various factors such as increasing investment for research and development, and advanced healthcare facilities like hospitals, blood banks, and clinics. The blood irradiation market in Germany is primarily driven by countries aging population, socio-political environment and high per capita healthcare expenditure.

 

 Europe Blood Irradiation Market Revenue and Forecast to 2028 (US$ Million)

 Europe Blood Irradiation Market Revenue and Forecast to 2028 (US$ Million)
Get more information on this report

Europe Blood Irradiation Strategic Insights

Strategic insights for the Europe Blood Irradiation provides data-driven analysis of the industry landscape, including current trends, key players, and regional nuances. These insights offer actionable recommendations, enabling readers to differentiate themselves from competitors by identifying untapped segments or developing unique value propositions. Leveraging data analytics, these insights help industry players anticipate the market shifts, whether investors, manufacturers, or other stakeholders. A future-oriented perspective is essential, helping stakeholders anticipate market shifts and position themselves for long-term success in this dynamic region. Ultimately, effective strategic insights empower readers to make informed decisions that drive profitability and achieve their business objectives within the market.

strategic-framework/europe-blood-irradiation-market-strategic-framework.webp
Get more information on this report

Europe Blood Irradiation Report Scope

Report Attribute Details
Market size in 2022 US$ 26.90 Million
Market Size by 2028 US$ 40.24 Million
Global CAGR (2022 - 2028) 6.9%
Historical Data 2020-2021
Forecast period 2023-2028
Segments Covered By Type
  • Intravenous Laser Blood Irradiation
  • Transcutaneous Laser Blood Irradiation
  • Extracorporeal Blood Irradiation
By Indication
  • Acute Leukemia
  • Lymphoma
  • Solid Tumors
  • Pelvic Tumors
By End User
  • Hospitals
  • Blood Banks
  • Diagnostics Clinics
  • Research Institutes
Regions and Countries Covered Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Market leaders and key company profiles
  • Hitachi, Ltd.
  • Best Theratronics Ltd.,
  • Gilardoni S.p.A.
  • Gamma-Service Medical GmbH
  • Typenex Medical
  • Actemium
  • Get more information on this report

    Europe Blood Irradiation Regional Insights

    The geographic scope of the Europe Blood Irradiation refers to the specific areas in which a business operates and competes. Understanding local distinctions, such as diverse consumer preferences (e.g., demand for specific plug types or battery backup durations), varying economic conditions, and regulatory environments, is crucial for tailoring strategies to specific markets. Businesses can expand their reach by identifying underserved areas or adapting their offerings to meet local demands. A clear market focus allows for more effective resource allocation, targeted marketing campaigns, and better positioning against local competitors, ultimately driving growth in those targeted areas.

    geography/europe-blood-irradiation-market-geography.webp
    Get more information on this report

     

                    

    Europe Blood Irradiation Market  Segmentation

     

    The Europe blood irradiation market is segmented into type , indication, end user, and country.

    • Based on type ,the market is segmented into intravenous laser blood irradiation, transcutaneous laser blood irradiation, and extracorporeal blood irradiation. The intravenous laser blood irradiation segment registered the largest market share in 2022.
    • Based on indication , the market is segmented into acute leukemia, lymphoma, solid tumors, pelvic tumors and others. The acute leukemia segment held the largest market share in 2022.
    • Based on end user, the market is segmented into hospitals, blood banks, diagnostics clinics, and research institutes. The hospital segment held the largest market share in 2022.
    • Based on country, the market is segmented into U.K., Germany, France, Italy, Spain and Rest of Europe. Germany dominated the market share in 2022.

    Hitachi, Ltd.; Best Theratronics Ltd.; Gilardoni S.p.A.; Gamma-Service Medical GmbH; Typenex Medical; and Actemium are the leading companies operating in the blood irradiation market in the region.   

    The List of Companies - Europe Blood Irradiation Market

    1. Hitachi, Ltd.                                                       
    2. Best Theratronics Ltd.,                                  
    3. Gilardoni S.p.A.                                                
    4. Gamma-Service Medical GmbH                
    5. Typenex Medical 
    6. Actemium          
    Frequently Asked Questions
    How big is the Europe Blood Irradiation Market?

    The Europe Blood Irradiation Market is valued at US$ 26.90 Million in 2022, it is projected to reach US$ 40.24 Million by 2028.

    What is the CAGR for Europe Blood Irradiation Market by (2022 - 2028)?

    As per our report Europe Blood Irradiation Market, the market size is valued at US$ 26.90 Million in 2022, projecting it to reach US$ 40.24 Million by 2028. This translates to a CAGR of approximately 6.9% during the forecast period.

    What segments are covered in this report?

    The Europe Blood Irradiation Market report typically cover these key segments-

  • Type (Intravenous Laser Blood Irradiation, Transcutaneous Laser Blood Irradiation, Extracorporeal Blood Irradiation)
  • Indication (Acute Leukemia, Lymphoma, Solid Tumors, Pelvic Tumors)
  • End User (Hospitals, Blood Banks, Diagnostics Clinics, Research Institutes)
  • What is the historic period, base year, and forecast period taken for Europe Blood Irradiation Market?

    The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the Europe Blood Irradiation Market report:

  • Historic Period : 2020-2021
  • Base Year : 2022
  • Forecast Period : 2023-2028
  • Who are the major players in Europe Blood Irradiation Market?

    The Europe Blood Irradiation Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:

  • Hitachi, Ltd.
  • Best Theratronics Ltd.,
  • Gilardoni S.p.A.
  • Gamma-Service Medical GmbH
  • Typenex Medical
  • Actemium
  • Who should buy this report?

    The Europe Blood Irradiation Market report is valuable for diverse stakeholders, including:

    • Investors: Provides insights for investment decisions pertaining to market growth, companies, or industry insights. Helps assess market attractiveness and potential returns.
    • Industry Players: Offers competitive intelligence, market sizing, and trend analysis to inform strategic planning, product development, and sales strategies.
    • Suppliers and Manufacturers: Helps understand market demand for components, materials, and services related to concerned industry.
    • Researchers and Consultants: Provides data and analysis for academic research, consulting projects, and market studies.
    • Financial Institutions: Helps assess risks and opportunities associated with financing or investing in the concerned market.

    Essentially, anyone involved in or considering involvement in the Europe Blood Irradiation Market value chain can benefit from the information contained in a comprehensive market report.